4.7 Article

Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks

期刊

BRAIN
卷 144, 期 -, 页码 3212-3225

出版社

OXFORD UNIV PRESS
DOI: 10.1093/brain/awab218

关键词

Lewy body dementia; tau; amyloid; resting-state fMRI; PET

资金

  1. National Institutes of Health, US [R01 AG040042, R01 AG11378, P50 AG16574, U01 AG06786, C06 RR018898]
  2. Foundation Dr Corinne Schulerand
  3. Mangurian Foundation for Lewy Body Research
  4. Elsie and Marvin Dekelboum Family Foundation
  5. Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program
  6. National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre (BRC) based at Newcastle upon Tyne Hospitals NHS Foundation Trust
  7. Newcastle University
  8. Alzheimer's Research UK

向作者/读者索取更多资源

The presence of concurrent Alzheimer's disease pathology in patients with DLB is associated with more severe loss of default mode network connectivity. Additionally, higher functional connectivity between brain regions is related to higher tau pathology levels in cognitively normal, Alzheimer's disease, and DLB patients.
Dementia with Lewy bodies (DLB) is neuropathologically defined by the presence of alpha-synudein aggregates, but many DLB cases show concurrent Alzheimer's disease pathology in the form of amyloid-beta plaques and tau neurofibrillary tangles. The first objective of this study was to investigate the effect of Alzheimer's disease co-pathology on functional network changes within the default mode network (DMN) in DLB. Second, we studied how the distribution of tau pathology measured with PET relates to functional connectivity in DLB. Twenty-seven DLB, 26 Alzheimer's disease and 99 cognitively unimpaired participants (balanced on age and sex to the DLB group) underwent tau-PET with AV-1451 (flortaucipir), amyloid-beta-PET with Pittsburgh compound-B (PiB) and resting-state functional MRI scans. The resing-state functional MRI data were used to assess functional connectivity within the posterior DMN. This was then correlated with overall cortical flortaucipir PET and PiB PET standardized uptake value ratio (SUVr). The strength of interregional functional connectivity was assessed using the Schaefer atlas. Tau-PET covariance was measured as the correlation in flortaucipir SUVr between any two regions across participants. The association between region-to-region functional connectivity and tau-PET covariance was assessed using linear regression. Additionally, we identified the region with highest and the region with lowest tau SUVrs (tau hot- and cold spots) and tested whether tau SUVr in all other brain regions was associated with the strength of functional connectivity to these tau hot and cold spots. A reduction in posterior DMN connectivity correlated with overall higher cortical tau- (r = -0.39, P = 0.04) and amyloid-PET uptake (r = -0.41, P = 0.03) in the DLB group, i.e. patients with DLB who have more concurrent Alzheimer's disease pathology showed a more severe loss of DMN connectivity. Higher functional connectivity between regions was associated with higher tau covariance in cognitively unimpaired, Alzheimer's disease and DLB. Furthermore, higher functional connectivity of a target region to the tau hotspot (ie. inferior/medial temporal cortex) was related to higher flortaucipir SUVrs in the target region, whereas higher functional connectivity to the tau cold spot (i.e. sensory-motor cortex) was related to lower flortaucipir SUVr in the target region. Our findings suggest that a higher burden of Alzheimer's disease co-pathology in patients with DLB is associated with more Alzheimer's disease-like changes in functional connectivity. Furthermore, we found an association between the brain's functional network architecture and the distribution of tau pathology that has recently been described in Alzheimer's disease. We show that this relationship also exists in patients with DLB, indicating that similar mechanisms of connectivity-dependent occurrence of tau pathology might be at work in both diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据